Vascular heterogeneity and specialization in development and disease. - Wikidata - awgldk - TriplyDB

Vascular heterogeneity and specialization in development and disease.

Vascular heterogeneity and specialization in development and disease.

http://www.wikidata.org/entity/Q39326100

about

Relaxin-2 in Cardiometabolic Diseases: Mechanisms of Action and Future Perspectives NRF2 regulates endothelial glycolysis and proliferation with miR-93 and mediates the effects of oxidized phospholipids on endothelial activation.Organ-specific lymphatic vasculature: From development to pathophysiology.The Human Blood-Nerve Barrier Transcriptome.Identification of Infants at Risk for Chronic Lung Disease at Birth. Potential for a Personalized Approach to Disease Prevention.The Pulmonary Vascular Barrier: Insights into Structure, Function, and Regulatory Mechanisms.Ebola Virus Localization in the Macaque Reproductive Tract during Acute Ebola Virus Disease.Prox1-GFP/Flt1-DsRed transgenic mice: an animal model for simultaneous live imaging of angiogenesis and lymphangiogenesis.Vascular Tissue Engineering: Progress, Challenges, and Clinical Promise.P53 Promotes Retinoid Acid-induced Smooth Muscle Cell Differentiation by Targeting Myocardin.PDCD5 says no to NO.Heterogeneity in VEGFR3 levels drives lymphatic vessel hyperplasia through cell-autonomous and non-cell-autonomous mechanisms.Inspired by Nature: Hydrogels as Versatile Tools for Vascular Engineering.EzColocalization: An ImageJ plugin for visualizing and measuring colocalization in cells and organisms Cellular and Molecular Heterogeneity Associated with Vessel Formation Processes Heterogeneity of tumor lymphangiogenesis: Progress and prospects Transcriptional and epigenomic landscapes of CNS and non-CNS vascular endothelial cells Microfluidic-Based 3D Engineered Microvascular Networks and Their Applications in Vascularized Microtumor Models

P2860

Q41463324-FBEECB42-5A00-4B1A-BD7B-E9BEE0D5C88F Q46257036-6210C986-28E0-477A-8CCC-39DD29F7E805 Q47248578-DBB01671-01F6-4591-B92C-54229BDEBD42 Q47300673-13B656B0-4E8E-4C80-8235-09FCE3205195 Q48279663-28C8F329-3F9D-4954-B003-043C3F52717F Q49484389-EE5AC141-961E-433E-8296-06793A4D6976 Q50076697-E2AC8B4C-1552-47A1-9CE5-F88779D2FDE1 Q50506414-111F7638-7EC4-4FB9-A5F4-7ED16FBFAAFA Q52677026-590CA77C-82BA-4D3E-851E-B845750E7F80 Q52684740-F1400C97-D98E-4E06-8C30-6850D7BBBF0E Q52718706-54305120-86F7-434A-BED2-B1E60CFC8417 Q55023685-3B71DCF6-64F6-42B6-BEFF-DAC2520164D2 Q55435403-7C71A38D-A585-40D5-8F50-F60C06410F0D Q58563081-D66741F0-377C-4EB3-A048-2D47AB9F0AF2 Q58575098-7096E3FA-5E00-4356-8DA9-CEC515AB6DBD Q58709934-0CAC999C-79BE-4F18-9055-892C5C477D61 Q58762072-EEB7A7A4-EBA4-4451-A917-B8EE5D66998F Q59126788-CB4E50A8-5D00-4CB1-AC40-9EA2F317A891

P2860

Vascular heterogeneity and specialization in development and disease.

http://www.wikidata.org/entity/Q39326100

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Vascular heterogeneity and specialization in development and disease.

@en

Vascular heterogeneity and specialization in development and disease.

@nl

type

label

Vascular heterogeneity and specialization in development and disease.

@en

Vascular heterogeneity and specialization in development and disease.

@nl

prefLabel

Vascular heterogeneity and specialization in development and disease.

@en

Vascular heterogeneity and specialization in development and disease.

@nl

P1433

Q39326100-712A0FFA-C53F-4939-9469-AC82982D36D0

P1476

Q39326100-2744DC6F-43F6-475E-AA8C-CF5F16BC35F5

P2093

Q39326100-7F8EB853-B3AC-4CAC-A949-4623EC9A18CD

P2860

Q39326100-01ADF817-BAA6-4E3F-A006-F0F1DD809BCC

Q39326100-03AD8311-9854-40E8-AA4C-A9495ABA0956

Q39326100-0423322D-8797-4C16-9288-1BC53F387198

Q39326100-043F32FE-6090-4C43-AD6A-8B9E9F6163AC

Q39326100-0471FA4D-1A09-49BE-9D5B-9A93E2BA72F8

Q39326100-05534A59-68C8-48B4-AF52-32C46668F275

Q39326100-05D63CEB-969F-43B4-BBBE-EF04C1CA96E5

Q39326100-079DAD25-3A93-475C-BCB9-4904F1D9B6D1

Q39326100-090CE888-65F0-49E1-A67B-E0972B991305

Q39326100-0ACB4DFD-0DA4-4144-8DBF-E8427C8B2C78

P2888

Q39326100-AEB78A39-6A8F-4411-83E0-2BEF06A961AB

P304

Q39326100-A1F7B4EF-C9FC-4ACA-96FD-59E439CB53D7

P31

Q39326100-E9096FA5-2215-4386-A507-78D85CA4AB6E

P356

Q39326100-8B7C3C35-4E13-4E9E-B7EC-45A2D56EA007

P433

Q39326100-75216BB5-74F0-4182-9293-A0896C67DAC9

P478

Q39326100-C468FF68-C9D9-4B4C-8621-4FC956DC876A

P50

Q39326100-A3C14717-997D-4FD4-A0C1-9EEB84BEF03D

P577

Q39326100-2367F797-297E-434D-88F7-2B4FFD517FD5

P698

Q39326100-0BA87612-8104-4972-AB15-CA5822720C88

P356

P1433

Nature Reviews Molecular Cell Biology

P1476

Vascular heterogeneity and specialization in development and disease

@en

P2093

Taija Mäkinen

http://www.w3.org/2001/XMLSchema#string

P2860

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome

Mutations in a novel factor, glomulin, are responsible for glomuvenous malformations ("glomangiomas")

Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice

Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2

Prox1 physically and functionally interacts with COUP-TFII to specify lymphatic endothelial cell fate

Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1

CCBE1 enhances lymphangiogenesis via A disintegrin and metalloprotease with thrombospondin motifs-3-mediated vascular endothelial growth factor-C activation

Mutations within the programmed cell death 10 gene cause cerebral cavernous malformations

Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations

P2888

P304

477-494

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRM.2017.36

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P50

Michael Potente

P577

2017-05-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28537573

http://www.w3.org/2001/XMLSchema#string